As the prevalence of respiratory diseases such as COVID-19 and COPD increases, so does the demand for oxygen therapy solutions and devices. To meet this demand, O2matic and Mediq have entered into a strategic partnership to bring O2Matic’s oxygen therapy solutions to the European market. ‘Mediq is a leading provider of medical devices and healthcare services that consistently focuses its innovation efforts on helping people with an illness or chronic health condition live higher quality lives. This partnership allows us to impact patient care on a greater scale’, says Farzad Saber, Chief Business Development Officer, O2matic ApS.

The distribution agreement is applicable in Denmark, Norway, Finland, the Baltics, the Netherlands and Belgium.

About Mediq
Every day, millions of patients and the dedicated professionals who care for them rely on the supply of medical devices and care solutions from Mediq. As a reliable partner for patients, healthcare professionals and healthcare insurers, Mediq continuously focuses on improving healthcare outcomes and the affordability of healthcare. Mediq was founded in 1899 and has leading market positions in 13 European countries. The head office is located in Utrecht.

About O2matic
O2matic ApS is a Danish MedTech ISO 13485 certified company that develops and manufactures respiratory solutions. In a field of amazingly talented scientists and companies, it was O2matic ApS who won the award for the most groundbreaking and innovative project in Denmark in 2020. With the Grand Solutions Award, the Innovation Fund rewards the excellent strategic research that focuses on solving socially important challenges.

16th of November 2020